The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa (Q64768272)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009191%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009191%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

1 reference

I Reuter

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009191%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

S Harder

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009191%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

M Engelhardt

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009191%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

H Baas

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009191%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009191%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009191%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009191%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009191%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

862-868

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009191%20AND%20SRC:MED&resulttype=core&format=json

Exercise and the antiparkinsonian response to levodopa

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C862%3A%3AAID-MDS1015%3E3.0.CO%3B2-S

The effect of exercise on levodopa absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C862%3A%3AAID-MDS1015%3E3.0.CO%3B2-S

Blood levodopa levels and unified Parkinson's disease rating scale function: with and without exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C862%3A%3AAID-MDS1015%3E3.0.CO%3B2-S

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C862%3A%3AAID-MDS1015%3E3.0.CO%3B2-S

Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C862%3A%3AAID-MDS1015%3E3.0.CO%3B2-S

The effects of acute levodopa withdrawal on motor performance and dopaminergic receptor sensitivity in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C862%3A%3AAID-MDS1015%3E3.0.CO%3B2-S

Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C862%3A%3AAID-MDS1015%3E3.0.CO%3B2-S

The use of kinetic-dynamic interactions in the evaluation of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C862%3A%3AAID-MDS1015%3E3.0.CO%3B2-S

Concentration-effect relationship of levodopa in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C862%3A%3AAID-MDS1015%3E3.0.CO%3B2-S

Concentration-effect relationship of levodopa in patients with Parkinson's disease after oral administration of an immediate release and a controlled release formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C862%3A%3AAID-MDS1015%3E3.0.CO%3B2-S

Longitudinal monitoring of the levodopa concentration-effect relationship in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C862%3A%3AAID-MDS1015%3E3.0.CO%3B2-S

Concentration-response relationship of levodopa in patients at different stages of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C862%3A%3AAID-MDS1015%3E3.0.CO%3B2-S

Effect of prolonged exercise on the passage of a solid meal through the stomach and small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C862%3A%3AAID-MDS1015%3E3.0.CO%3B2-S

A levodopa kinetic-dynamic study of the rate of progression in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C862%3A%3AAID-MDS1015%3E3.0.CO%3B2-S

10.1002/1531-8257(200009)15:5<862::AID-MDS1015>3.0.CO;2-S

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11009191%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference